3rd Quarter - Report

340B HEALTH for 340B HEALTH

Firm
Client
Income
—
Expenses
$241,326
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

S. 1239; H.R. 444; H.R. 4213; Extending 340B Drug Discount Program to the inpatient setting in eligible hospitals and improving program integrity. Preserving current 340B patient definition; Improving Medicaid reimbursement to 340B covered entities; reversing 340B orphan drug prohibition for certain covered entities.

LobbyistCovered position, as disclosed
VICTORIA AUFIERO —
JEFFREY IRVING DAVIS New Staff for Rep. Berkley
GREG DOGGETT New —
NISHA KAPUR New Intern for Rep. Courtney
TED SLAFSKY Fellow for Dem Policy Committee 1994
JAIMIE VICKERY Staff for Reps. Horn and Biggert
WILLIAM VON OEHSEN —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA)

Bills named: H.R. 4213 (111th), S. 1239 (111th), H.R. 444 (111th)

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.